146 related articles for article (PubMed ID: 9751936)
1. Hybridization of a 99Tcm-labelled oligodeoxynucleotide to CAPL RNA.
Hjelstuen OK; Maelandsmo GM; Tønnesen HH; Bremmer PO; Verbruggen AM
Nucl Med Commun; 1998 Aug; 19(8):803-12. PubMed ID: 9751936
[TBL] [Abstract][Full Text] [Related]
2. 3'-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide.
Hjelstuen OK; Tønnesen HH; Bremer PO; Verbruggen AM
Nucl Med Biol; 1998 Oct; 25(7):651-7. PubMed ID: 9804046
[TBL] [Abstract][Full Text] [Related]
3. Hybridisation of [76Br]-labelled antisense oligonucleotides to Chromogranin A mRNA verified by RT-PCR.
Wu F; Lendvai G; Yngve U; Eriksson B; Långström B; Bergström M
Nucl Med Biol; 2004 Nov; 31(8):1073-8. PubMed ID: 15607489
[TBL] [Abstract][Full Text] [Related]
4. Hybridization and cell uptake studies with radiolabelled antisense oligonucleotides.
Stalteri MA; Mather SJ
Nucl Med Commun; 2001 Nov; 22(11):1171-9. PubMed ID: 11606881
[TBL] [Abstract][Full Text] [Related]
5. G/C-modified oligodeoxynucleotides with selective complementarity: synthesis and hybridization properties.
Woo J; Meyer RB; Gamper HB
Nucleic Acids Res; 1996 Jul; 24(13):2470-5. PubMed ID: 8692683
[TBL] [Abstract][Full Text] [Related]
6. Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design.
Lu ZJ; Mathews DH
Nucleic Acids Res; 2008 Jun; 36(11):3738-45. PubMed ID: 18483081
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
[TBL] [Abstract][Full Text] [Related]
8. Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm.
Qu T; Wang Y; Zhu Z; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2001 Feb; 22(2):203-15. PubMed ID: 11258408
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes.
Laktionov PP; Dazard JE; Vives E; Rykova EY; Piette J; Vlassov VV; Lebleu B
Nucleic Acids Res; 1999 Jun; 27(11):2315-24. PubMed ID: 10325420
[TBL] [Abstract][Full Text] [Related]
10. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
[TBL] [Abstract][Full Text] [Related]
11. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Maelandsmo GM; Hovig E; Skrede M; Engebraaten O; Flørenes VA; Myklebost O; Grigorian M; Lukanidin E; Scanlon KJ; Fodstad O
Cancer Res; 1996 Dec; 56(23):5490-8. PubMed ID: 8968106
[TBL] [Abstract][Full Text] [Related]
12. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
[TBL] [Abstract][Full Text] [Related]
13. Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET).
Sixou S; Szoka FC; Green GA; Giusti B; Zon G; Chin DJ
Nucleic Acids Res; 1994 Feb; 22(4):662-8. PubMed ID: 8127715
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
16. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
[TBL] [Abstract][Full Text] [Related]
18. S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart.
Engelkamp D; Schäfer BW; Erne P; Heizmann CW
Biochemistry; 1992 Oct; 31(42):10258-64. PubMed ID: 1384693
[TBL] [Abstract][Full Text] [Related]
19. Oligodeoxynucleotides containing C-7 propyne analogs of 7-deaza-2'-deoxyguanosine and 7-deaza-2'-deoxyadenosine.
Buhr CA; Wagner RW; Grant D; Froehler BC
Nucleic Acids Res; 1996 Aug; 24(15):2974-80. PubMed ID: 8760882
[TBL] [Abstract][Full Text] [Related]
20. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
